Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

New agency

- PMLiVE

Bluebird’s myeloma CAR-T safety ‘could support outpatient use’

Expects to file with the FDA next year

- PMLiVE

Shingrix lifts GSK in Q1, but two more vaccines are culled

Synflorix follow-up and influenza vaccine fail to make the cut

Biogen Idec building

Biogen’s tofersen shows promise in slowing down ALS

Hope for subset of patients with wasting disease

Eli Lilly HQ

Pricing pressures peg back Lilly’s growth products

Reduces its full year forecast as a result

- PMLiVE

Novo Nordisk targets renewable energy switch by 2030

Huge solar panel array helps transition

- PMLiVE

Bicycle Therapeutics looks to raise $86m with IPO

Key data readout expected later this year

- PMLiVE

Solid Q1 results lift Pfizer as it waits for pipeline boost

Shares rose almost 2% in the wake of the presentation

Apex and Lumentium bring a new experience to the UK event market

Specialist pharma conference and event management company Apex has signed an exclusive deal to become the sole representative of Lumentium in the UK.

Apex Events and Exhibitions

The inescapable rise of patient-centricity

The April issue of PME questions the meaning of ‘patient-centricity’ and whether we are achieving it.Patient-centricity has become a ubiquitous value within the pharmaceutical industry; however, is pharma delivering on...

Lucid Group Communications Limited

- PMLiVE

European approval for Skyrizi, hot on the heels of US

Welcome news, but can't replace $20bn Humira

- PMLiVE

Gilead gets ‘gold’ in England’s hepatitis C eradication drive

NHS England's tender process drives down cost of medicines

- PMLiVE

Brexit clock ticking once again, UK heads for European elections

New deadline gives pharma more time, but no more clarity

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links